London School of Hygiene & Tropical Medicine, WC1E 7HT, London, UK.
Research Institute of Internal and Preventive Medicine, Branch of Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090, Russia.
BMC Cardiovasc Disord. 2020 Mar 13;20(1):135. doi: 10.1186/s12872-020-01407-2.
Uncontrolled hypertension is a major cardiovascular risk factor. We examined uncontrolled hypertension and differences in treatment regimens between a high-risk country, Russia, and low-risk Norway to gain better understanding of the underlying factors.
Population-based survey data on 40-69 year olds with hypertension defined as taking antihypertensives and/or having high blood pressure (140+/90+ mmHg) were obtained from Know Your Heart Study (KYH, N = 2284), Russian Federation (2015-2018) and seventh wave of The Tromsø Study (Tromsø 7, N = 5939), Norway (2015-2016). Uncontrolled hypertension was studied in the subset taking antihypertensives (KYH: N = 1584; Tromsø 7: 2792)and defined as having high blood pressure (140+/90+ mmHg). Apparent treatment resistant hypertension (aTRH) was defined as individuals with uncontrolled hypertension on 3+ OR controlled on 4+ antihypertensive classes in the same subset.
Among all those with hypertension regardless of treatment status, control of blood pressure was achieved in 22% of men (KYH and Tromsø 7), while among women it was 33% in Tromsø 7 and 43% in KYH. When the analysis was limited to those on treatment for hypertension, the percentage uncontrolled was higher in KYH (47.8%, CI 95 44.6-50.9%) than Tromsø 7 (38.2, 36.1-40.5%). The corresponding figures for aTRH were 9.8% (8.2-11.7%) and 5.7% (4.8-6.8%). Antihypertensive monotherapies were more common than combinations and used by 58% in Tromsø 7 and 44% in KYH. In both KYH and Tromsø 7, untreated hypertension was higher in men, those with no GP visit in the past year and problem drinkers. In both studies, aTRH was associated with older age, CVD history, obesity, and diabetes. In Tromsø 7, also male gender and any drinking. In KYH, also chronic kidney disease.
There is considerable scope for promoting combination therapies in line with European treatment guidelines in both study populations. The factors associated with untreated hypertension overlap with known correlates of treatment non-adherence and health check non-attendance. In contrast, aTRH was characterised by obesity and underlying comorbidities potentially complicating treatment.
未控制的高血压是心血管的主要危险因素之一。我们研究了高危国家俄罗斯和低危国家挪威的未控制高血压和治疗方案差异,以更好地了解潜在的因素。
2015-2018 年,我们从俄罗斯联邦的“了解你的心脏”研究(KYH,N=2284)和 2015-2016 年挪威的特罗姆瑟研究第 7 波(Tromsø 7,N=5939)中获得了 40-69 岁高血压患者(定义为服用抗高血压药物和/或血压高(140+/90+mmHg))的基于人群的调查数据。在服用抗高血压药物的亚组(KYH:N=1584;Tromsø 7:2792)中研究了未控制的高血压,并将其定义为血压高(140+/90+mmHg)。将明显的治疗抵抗性高血压(aTRH)定义为在同一亚组中,有 3+或 4+种以上抗高血压药物的未控制高血压的个体。
无论治疗状态如何,所有高血压患者中,血压控制在男性中达到 22%(KYH 和 Tromsø 7),而在女性中,Tromsø 7 中为 33%,KYH 中为 43%。当分析仅限于接受高血压治疗的患者时,KYH 的未控制率(47.8%,95%CI 95 44.6-50.9%)高于 Tromsø 7(38.2%,36.1-40.5%)。相应的 aTRH 数据分别为 9.8%(8.2-11.7%)和 5.7%(4.8-6.8%)。抗高血压单药治疗比联合治疗更常见,Tromsø 7 中占 58%,KYH 中占 44%。在 KYH 和 Tromsø 7 中,男性、过去一年没有看全科医生的人以及酗酒者的未治疗高血压更高。在这两项研究中,aTRH 与年龄较大、心血管疾病史、肥胖和糖尿病有关。在 Tromsø 7 中,还与男性性别和任何饮酒有关。在 KYH 中,还与慢性肾脏病有关。
在这两个研究人群中,根据欧洲治疗指南,有相当大的空间可以推广联合治疗。与治疗不依从和健康检查不参加相关的未治疗高血压的相关因素与已知的相关因素重叠。相比之下,aTRH 的特点是肥胖和潜在的合并症,可能使治疗复杂化。